The new end-tidal CO2 monitors can be used in a range of medical monitoring applications, including resuscitation, procedural sedation, pain management, post-anesthesia monitoring and sleep testing.

Both devices provide clinicians with first-breath detection technology for respiratory rate and end-tidal CO2 (EtCO2).

LifeSense II also features the company's PureSAT SpO2 technology that uses intelligent pulse-by-pulse filtering to offer precise oximetry measurements.

The company said the new devices offer 36-hour internal memory with USB port, as well as configurable selections for language, units of measurement and alarms.

Nonin Medical marketing senior director said: "The LifeSense II and RespSense II, with their accuracy, ease of use, cost effectiveness and leading warranty, provide tremendous value for a variety of applications and markets; including hospital, homecare, sleep labs and EMS.”

The company is exhibiting the new devices at the American Association for Respiratory Care (AARC) Congress in San Antonio, Texas. The event will end on 18 October.

In June, the company launched new NoninConnect Elite model 3240 Bluetooth smart wireless finger pulse oximeter.

Featuring PureSAT pulse oximetry technology, the NoninConnect Elite measures arterial blood oxygen saturation and pulse rate of the patients.

With operations in around 125 countries, Nonin Medical designs and manufactures noninvasive medical monitoring solutions.

The company produces pulse and regional oximeters, capnographs, sensors and software for health professionals and consumers.

Image: Nonin Medical's RespSense II capnograph and LifeSense II capnograph/pulse oximeter. Photo: courtesy of PRNewsFoto/Nonin Medical, Inc.